These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20471510)

  • 1. Treatment with p38 inhibitor partially prevents Calu-6 lung cancer cell death by a proteasome inhibitor, MG132.
    Han YH; Park WH
    Cancer Genet Cytogenet; 2010 Jun; 199(2):81-8. PubMed ID: 20471510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitogen-activated protein kinase inhibitors differently affect the growth inhibition and death of a proteasome inhibitor, MG132-treated human pulmonary fibroblast cells.
    Park WH
    Hum Exp Toxicol; 2011 Dec; 30(12):1945-54. PubMed ID: 21421692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The attenuation of MG132, a proteasome inhibitor, induced A549 lung cancer cell death by p38 inhibitor in ROS-independent manner.
    Han YH; Moon HJ; You BR; Park WH
    Oncol Res; 2010; 18(7):315-22. PubMed ID: 20377132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Anticancer Res; 2009 Oct; 29(10):3837-44. PubMed ID: 19846917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MG132, a proteasome inhibitor decreased the growth of Calu-6 lung cancer cells via apoptosis and GSH depletion.
    Han YH; Park WH
    Toxicol In Vitro; 2010 Jun; 24(4):1237-42. PubMed ID: 20149858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of N-acetyl cysteine on the MG132 proteasome inhibitor-treated lung cancer cells in relation to cell growth, reactive oxygen species and glutathione.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Int J Mol Med; 2010 Apr; 25(4):657-62. PubMed ID: 20198316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with p38 inhibitor intensifies the death of MG132-treated As4.1 juxtaglomerular cells via the enhancement of GSH depletion.
    Han YH; Kim SZ; Kim SH; Park WH
    Drug Chem Toxicol; 2010 Oct; 33(4):367-76. PubMed ID: 20545600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MG132 as a proteasome inhibitor induces cell growth inhibition and cell death in A549 lung cancer cells via influencing reactive oxygen species and GSH level.
    Han YH; Park WH
    Hum Exp Toxicol; 2010 Jul; 29(7):607-14. PubMed ID: 20053704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of MAPK inhibitors on pyrogallol-treated Calu-6 lung cancer cells in relation to cell growth, reactive oxygen species and glutathione.
    Han YH; Moon HJ; You BR; Park WH
    Food Chem Toxicol; 2010 Jan; 48(1):271-6. PubMed ID: 19833163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MG132, a proteasome inhibitor-induced calf pulmonary arterial endothelial cell growth and death, are changed by MAPK inhibitors.
    You BR; Park WH
    Drug Chem Toxicol; 2011 Jan; 34(1):45-52. PubMed ID: 20954830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of N-acetyl cysteine, buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on antimycin A-treated Calu-6 lung cells in relation to cell growth, reactive oxygen species and glutathione.
    Han YH; Park WH
    Oncol Rep; 2009 Aug; 22(2):385-91. PubMed ID: 19578781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of MAPK inhibitors on a proteasome inhibitor, MG132-induced HeLa cell death in relation to reactive oxygen species and glutathione.
    Han YH; Park WH
    Toxicol Lett; 2010 Feb; 192(2):134-40. PubMed ID: 19854251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of MG132, a proteasome inhibitor on HeLa cells in relation to cell growth, reactive oxygen species and GSH.
    Han YH; Moon HJ; You BR; Park WH
    Oncol Rep; 2009 Jul; 22(1):215-21. PubMed ID: 19513526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of MAPK inhibitors on antimycin A-treated Calu-6 lung cancer cells in relation to cell growth, reactive oxygen species, and glutathione.
    Han YH; Park WH
    Mol Cell Biochem; 2010 Jan; 333(1-2):211-9. PubMed ID: 19714450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p38 inhibitor intensified cell death in antimycin A-treated As4.1 juxtaglomerular cells via the enhancement of GSH depletion.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Anticancer Res; 2009 Nov; 29(11):4423-31. PubMed ID: 20032388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive oxygen species and glutathione level changes by a proteasome inhibitor, MG132, partially affect calf pulmonary arterial endothelial cell death.
    Han YH; Kim SZ; Kim SH; Park WH
    Drug Chem Toxicol; 2010 Oct; 33(4):403-9. PubMed ID: 20088736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspase inhibitor decreases apoptosis in pyrogallol-treated lung cancer Calu-6 cells via the prevention of GSH depletion.
    Han YH; Kim SH; Kim SZ; Park WH
    Int J Oncol; 2008 Nov; 33(5):1099-105. PubMed ID: 18949374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced cell death effects of MAP kinase inhibitors in propyl gallate-treated lung cancer cells are related to increased ROS levels and GSH depletion.
    Park WH
    Toxicol In Vitro; 2021 Aug; 74():105176. PubMed ID: 33865947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The changes of reactive oxygen species and glutathione by MG132, a proteasome inhibitor affect As4.1 juxtaglomerular cell growth and death.
    Han YH; Park WH
    Chem Biol Interact; 2010 Mar; 184(3):319-27. PubMed ID: 20100472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAPK inhibitors augment gallic acid-induced A549 lung cancer cell death through the enhancement of glutathione depletion.
    Park WH; Kim SH
    Oncol Rep; 2013 Jul; 30(1):513-9. PubMed ID: 23660987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.